1. Acute Leukemia Group B (1975) Correlation of abnormal immunoglobin with clinical features of myeloma. Arch Intern Med 135:46–52
2. Alexanian R (1980) Localized and indolent myeloma. Blood 56:521
3. Alexanian R, Balcerzak S, Bonnet JD, Gehan EA, Haut A, Hewlett JS, Monto RW (1975) Prognostic factors in multiple myeloma. Cancer 36:1192–1201
4. Belpomme D, Simon F, Pouillart P, Amor B, Feuilhade de Chauvin F, Belpomme A, Menkes C, Delrieu A, Depierre R, Le Mevel B, Serrou B, Fries D, Delbarre F, Mathé G (1978) Prognostic factors and treatment of multiple myeloma: Interest of a cyclic sequential chemohormonotherapy combining cyclophosphamide, melphalan, and prednisone. In: Mathé G, Seligman M, Tubiana M (eds) Recent results in cancer research. Lymphoid neoplasias. II. Clinical and therapeutic aspects. Springer, Berlin Heidelberg New York, p 28–40
5. Bergsagel DE, Bailey AJ, Langley GR, MacDonald RN, White DF, Miller AB (1979) The chemotherapy of plasmacell myeloma and the incidence of acute leukemia. N Engl J Med 301:743–748